← Back to directory
Busyamas Chewaskulyong
Researcher Next ID · RN-012930
Researcher · Medicine
, Thailand
Not currently recruitingFunding unknown
- Works count
- 35
- Citation count
- 17,932
- H-index
- 12
- i10-index
- 16
Research interests
Medicine
Lung Cancer Treatments and Mutations
Lung Cancer Research Studies
Lung Cancer Diagnosis and Treatment
Cancer Immunotherapy and Biomarkers
Gastric Cancer Management and Outcomes
Publications
Overall Survival with Osimertinib in Untreated, EGFR -Mutated Advanced NSCLC
New England Journal of Medicine · 2019 · 10.1056/nejmoa1913662
Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study
The Lancet Oncology · 2018 · 10.1016/s1470-2045(18)30144-x
Osimertinib in Untreated EGFR -Mutated Advanced Non–Small-Cell Lung Cancer
New England Journal of Medicine · 2017 · 10.1056/nejmoa1713137
Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
New England Journal of Medicine · 2009 · 10.1056/nejmoa0810699
Current projects
No projects listed.